Leap Therapeutics, Inc.

NasdaqCM:LPTX Stock Report

Market Cap: US$111.5m

Leap Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LPTX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies2,1360.00557%
Individual Insiders355,8710.929%
VC/PE Firms2,442,3526.37%
Hedge Funds3,085,1048.05%
Public Companies6,534,45417.1%
Institutions9,890,70325.8%
General Public16,007,27741.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 49.9%.

Top Shareholders

Top 25 shareholders own 57.1% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.9%
Gilead Sciences, Inc.
5,319,148US$15.5m0%no data
8.05%
Balyasny Asset Management L.P.
3,085,104US$9.0m-0.48%0.02%
6.37%
Samsara BioCapital LLC
2,442,352US$7.1m0%0.94%
3.6%
683 Capital Management, LLC
1,380,500US$4.0m6.19%0.4%
3.31%
Rock Springs Capital Management LP
1,266,546US$3.7m0%0.12%
3.17%
BeiGene, Ltd.
1,215,306US$3.5m65.4%no data
3.06%
Baker Bros. Advisors LP
1,172,175US$3.4m0%0.03%
2.76%
Simplify Asset Management Inc.
1,056,895US$3.1m67.4%0.2%
2.69%
The Vanguard Group, Inc.
1,029,153US$3.0m3.3%no data
1.85%
Laurion Capital Management LP
709,219US$2.1m0%0.13%
1.77%
HealthCare Ventures LLC
676,320US$2.0m0%100.0%
1.21%
Citadel Advisors LLC
463,448US$1.3m-49.5%no data
0.86%
Geode Capital Management, LLC
329,291US$958.2k18%no data
0.84%
Key Client Fiduciary Advisors, LLC
321,923US$936.8k13%0.41%
0.68%
James Cavanaugh
262,053US$762.6k0%no data
0.53%
BlackRock, Inc.
202,963US$590.6k18%no data
0.48%
Acadian Asset Management LLC
183,663US$534.5k-28.4%no data
0.43%
UBS O'Connor LLC
165,108US$480.5k10.2%0.04%
0.31%
Acuta Capital Partners, LLC
120,500US$350.7k-38.2%0.3%
0.27%
Exome Asset Management LLC
102,631US$298.7k0%0.2%
0.21%
Dimensional Fund Advisors LP
81,463US$237.1k27.3%no data
0.21%
HANSAINVEST Hanseatische Investment-GmbH
81,000US$235.7k0%0.02%
0.19%
Douglas Onsi
73,646US$214.3k0%no data
0.19%
State Street Global Advisors, Inc.
71,813US$209.0k0%no data
0.17%
Susquehanna International Group, LLP, Asset Management Arm
66,246US$192.8k453%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 19:11
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Leap Therapeutics, Inc. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Madhu KumarBaird
Joel BeattyBaird
Swayampakula RamakanthH.C. Wainwright & Co.